Proceedings of the International Cancer Imaging Society (ICIS) 16th Annual Teaching Course

Autor: Dow-Mu Koh, Sue Creviston Kaste, Sarah J. Vinnicombe, Giovanni Morana, Andrea Rossi, Christian J. Herold, Theresa C. McLoud, Kirk A. Frey, Bernhard Gebauer, Derek Roebuck, Jurgen J. Fütterer, Alexander J. Towbin, Thierry A. G. Huisman, Anne M. J. B. Smets, Jeong Min Lee, Hersh Chandarana, Marius E. Mayerhoefer, Markus Raderer, Alexander Haug, Matthias Eiber, Andrea Rockall, Aslam Sohaib, Victoria S Warbey, Hebert Alberto Vargas, Jay P. Heiken, Isaac R. Francis, Mahmoud M. Al-Hawary, Ravi K. Kaza, Mirko D’Onofrio, Harriet C. Thoeny, Ann D. King, Arnoldo Piccardo, Maria Luisa Garrè, Nick Reed, Carlos Rodriguez-Galindo, Ashish P. Wasnik, Stefan Diederich, Wim J. G. Oyen, Cheng Lee Chaw, Nicholas van As, Igor Vieira, Frederik De Keyzer, Elleke Dresen, Sileny Han, Ignace Vergote, Philippe Moerman, Frederic Amant, Michel Koole, Vincent Vandecaveye, R. Dresen, S. De Vuysere, F. De Keyzer, E. Van Cutsem, A. D’Hoore, A. Wolthuis, V. Vandecaveye, P. Pricolo, S. Alessi, P. Summers, E. Tagliabue, G. Petralia, C. Pfannenberg, B. Gückel, S. C. Schüle, A. C. Müller, S. Kaufmann, N. Schwenzer, M. Reimold, C. la Fougere, K. Nikolaou, P. Martus, G. J. Cook, G. K. Azad, B. P. Taylor, M. Siddique, J. John, J. Mansi, M. Harries, V. Goh, S. Seth, R. Burgul, A. Seth, S. Waugh, N. Muhammad Gowdh, C. Purdie, A. Evans, E. Crowe, A. Thompson, S. Vinnicombe, F. Arfeen, T. Campion, E. Goldstraw, M. D’Onofrio, V. Ciaravino, S. Crosara, R. De Robertis, R. Pozzi Mucelli, M. Uhrig, D. Simons, H. Schlemmer, Kate Downey, S. Murdoch, A. S. Al-adhami, S. Viswanathan, S. Smith, P. Jennings, D. Bowers, R. Soomal, T. M. Mutala, A. O. Odhiambo, N. Harish, M. Hall, M. Sproule, S. Sheridan, K. Y. Thein, C. H. Tan, Y. L. Thian, C. M. Ho, S. De Luca, C. Carrera, V. Blanchet, L. Alarcón, E. Eyheremnedy, B. K. Choudhury, K. Bujarbarua, G. Barman, E. Lovat, R. Ferner, V. S. Warbey, L. Potti, B. Kaye, A. Beattie, K. Dutton, A. A. Seth, F. Constantinidis, H. Dobson, R. Bradley, G. Bozas, G. Avery, A. Stephens, A. Maraveyas, S. Bhuva, C. A. Johnson, M. Subesinghe, N. Taylor, L. E. Quint, R. M. Reddy, G. P. Kalemkerian, G. González Zapico, E. Gainza Jauregui, R. Álvarez Francisco, S. Ibáñez Alonso, I. Tavera Bahillo, L. Múgica Álvarez, O. Francies, R. Wheeler, L. Childs, A. Adams, A. Sahdev, S. E. De Luca, M. E. Casalini Vañek, M. D. Pascuzzi, T. Gillanders, P. M. Ramos, E. P. Eyheremendy, C. Stove, M. Digby, M. Nazar, M. Wirtz, F. Troncoso, F. Saguier, D. J. Quint, L. Dang, M. Carlson, S. Leber, F. Silverstein, R. Rueben, B. Nazir, T. H. Teo, J. B. Khoo, K. Sharma, N. Gupta, B. Mathew, T. Jeyakumar, K. Harkins, S. Joshua, D. Christodoulou, S. Gourtsoyianni, A. Jacques, N. Griffin, J. Lee, J. A. Goodfellow, A. Yong, S. Jenkins, G. Joseph, K. Partington, A. Zanfardini, K. Cavanagh, E. Lau

Publikováno v: Cancer Imaging, Vol 16, Iss S1, Pp 1-34 (2016)

Table of contents O1 Tumour heterogeneity: what does it mean? Dow-Mu Koh O2 Skeletal sequelae in adult survivors of childhood cancer Sue Creviston Kaste O3 Locoregional effects of breast cancer treatment Sarah J Vinnicombe O4 Imaging of cancer therap

Externí odkaz: https://doaj.org/article/bbc9ed6b29934836b9bbcd92740a4db6

Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer

Autor: C.J.A. Punt, V. Heinemann, T. Maughan, C. Cremolini, E. Van Cutsem, R. McDermott, G. Bodoky, T. André, P. Osterlund, A.J. Teske, P. Pfeiffer

BACKGROUND: Fluoropyrimidines (FPs) are an essential part of the majority of systemic regimens in the treatment of metastatic colorectal cancer (CRC). The use of the oral FP S-1 has been approved by the European Medicines Agency as monotherapy or in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f39f40088f1dd2a8e34b10c1e576b40c
https://lirias.kuleuven.be/handle/20.500.12942/720325

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study

Autor: E. Van Cutsem, I. Danielewicz, M. P. Saunders, P. Pfeiffer, G. Argilés, C. Borg, R. Glynne-Jones, C. J. A. Punt, A. J. Van de Wouw, M. Fedyanin, D. Stroyakovskiy, H. Kroening, P. Garcia-Alfonso, H. Wasan, A. Falcone, R. Fougeray, A. Egorov, N. Amellal, V. Moiseyenko

Publikováno v: British journal of cancer, 126(11), 1548-1554. Nature Publishing Group
Scientia

Background Therapeutic options are limited in patients with unresectable metastatic colorectal cancer (mCRC) ineligible for intensive chemotherapy. The use of trifluridine/tipiracil plus bevacizumab (TT-B) in this setting was evaluated in the TASCO1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03af4faff5144bcdcf5517b7b9e24306
https://doi.org/10.1038/s41416-022-01737-2